Literature DB >> 16497513

Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis.

Marcel Thalen1, Marian Venema, Jan van den IJssel, Luc Berwald, Coen Beuvery, Dirk Martens, Johannes Tramper.   

Abstract

Whooping cough vaccines are produced using different ranges of cultivation conditions and medium compositions, which are known to influence growth rate, virulence factor production and degradation, as well as the virulence factors' association to the cell. This study quantifies the impact of individual parameters on Pertussis Toxin (PT) production, using an optimized chemically defined medium as starting point, rather than a complex medium. A number of chemicals that are identified affect both growth rate and virulence factor production, which occur at similar levels in various commonly used production media. Also, degradation by proteolytic activity is shown to be an important parameter to monitor, since it significantly affects the PT yield. Low sodium concentrations, i.e. 50-75 mM rather than the conventional 100-140 mM, significantly increase the growth rate of the organism, the final optical density, as well as the association of PT to the cells. The absolute amount of biomass produced measured as dry weight, is similar for all sodium concentrations tested, contrary to earlier work. While it is known that high iron concentrations inhibit virulence factor production, it is shown here that iron-limited growth results in very high specific PT production. This finding may be used to produce a whole-cell vaccine with little biomass per dose, reducing whole-cell vaccine toxicity. The Bordetella pertussis strain 509 used here produces 30% more PT at 34 than at 37 degrees C, a commonly used cultivation temperature. The data in this study show that existing production processes for cellular and acellular vaccines can in principle be optimised considerably by taking simple measures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497513     DOI: 10.1016/j.biologicals.2005.11.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  6 in total

Review 1.  Development of improved pertussis vaccine.

Authors:  Martin Rumbo; Daniela Hozbor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  A curated genome-scale metabolic model of Bordetella pertussis metabolism.

Authors:  Nick Fyson; Jerry King; Thomas Belcher; Andrew Preston; Caroline Colijn
Journal:  PLoS Comput Biol       Date:  2017-07-17       Impact factor: 4.475

3.  Probing the Genome-Scale Metabolic Landscape of Bordetella pertussis, the Causative Agent of Whooping Cough.

Authors:  Filipe Branco Dos Santos; Brett G Olivier; Joost Boele; Vincent Smessaert; Philippe De Rop; Petra Krumpochova; Gunnar W Klau; Martin Giera; Philippe Dehottay; Bas Teusink; Philippe Goffin
Journal:  Appl Environ Microbiol       Date:  2017-10-17       Impact factor: 4.792

4.  Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains.

Authors:  Audrey J King; Saskia van der Lee; Archena Mohangoo; Marjolein van Gent; Arno van der Ark; Bas van de Waterbeemd
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

5.  Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.

Authors:  Marieke E Hoonakker; Lisa M Verhagen; Elder Pupo; Alex de Haan; Bernard Metz; Coenraad F M Hendriksen; Wanda G H Han; Arjen Sloots
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

6.  Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1.

Authors:  Marcel Thalen; Anne-Sophie Debrie; Loic Coutte; Dominique Raze; Ken Solovay; Keith Rubin; Nathalie Mielcarek; Camille Locht
Journal:  Vaccines (Basel)       Date:  2020-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.